Y. Zimmerman

发表

Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: I. Endocrine effects.

J. Foidart, B. Fauser, K. Cobey, 2015, Contraception.

Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: II. Clinical effects.

J. Foidart, B. Fauser, K. Cobey, 2015, Contraception.

The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol- and drospirenone-containing oral contraceptive

B. Fauser, H. C. Coelingh Bennink, Y. Zimmerman, 2013, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Maintaining physiologic testosterone levels during combined oral contraceptives by adding dehydroepiandrosterone: II. Effects on sexual function. A phase II randomized, double-blind, placebo-controlled study.

E. Laan, B. Fauser, R. V. van Lunsen, 2018, Contraception.

Clinical effects of the fetal estrogen estetrol in a multiple-rising-dose study in postmenopausal women.

J. Foidart, H. C. Coelingh Bennink, C. Verhoeven, 2016, Maturitas.

Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study

J. Foidart, H. C. Coelingh Bennink, C. Klipping, 2015, European journal of contraception & reproductive health care.

Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives

J. Foidart, H. C. Coelingh Bennink, C. Klipping, 2015, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects.

E. Laan, B. Fauser, R. V. van Lunsen, 2017, Contraception.

A novel treatment strategy for ovarian cancer based on immunization against zona pellucida protein (ZP) 3

I. Huhtaniemi, R. Dina, S. Ghaem-Maghami, 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Reported jealousy differs as a function of menstrual cycle stage and contraceptive pill use: a within-subjects investigation

Susan C. Roberts, K. Cobey, A. Buunk, 2012 .

Pharmacodynamic effects of the fetal estrogen estetrol in postmenopausal women: results from a multiple-rising-dose study

J. Foidart, H. C. Coelingh Bennink, C. Verhoeven, 2017, Menopause.

A Dose-Escalating Study With the Fetal Estrogen Estetrol in Healthy Men

C. Kluft, H. C. Coelingh Bennink, C. Verhoeven, 2018, The Journal of clinical endocrinology and metabolism.

Peculiar observations in measuring testosterone in women treated with oral contraceptives supplemented with dehydroepiandrosterone (DHEA).

T. de Boer, M. Blankenstein, A. Heijboer, 2014, Clinica chimica acta; international journal of clinical chemistry.

Estetrol Cotreatment of Androgen Deprivation Therapy in Infiltrating or Metastatic, Castration-sensitive Prostate Cancer: A Randomized, Double-blind, Phase II Trial (PCombi)

F. Saad, H. V. van Melick, D. Somford, 2021, European urology open science.

Pharmacokinetics of the fetal estrogen estetrol in a multiple-rising-dose study in postmenopausal women

J. Foidart, H. C. Coelingh Bennink, C. Verhoeven, 2017, Climacteric : the journal of the International Menopause Society.

Reduced hemostatic effects with drospirenone-based oral contraceptives containing estetrol vs. ethinyl estradiol.

J. Foidart, C. Kluft, C. Klipping, 2017, Contraception.

The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis

M. Eijkemans, M. Blankenstein, B. Fauser, 2013, Human reproduction update.

Estetrol Prevents Hot Flushes and Improves Quality of Life in Patients with Advanced Prostate Cancer Treated with Androgen Deprivation Therapy: The PCombi Study

H. V. van Melick, D. Somford, M. Frydenberg, 2022, European urology open science.

Tumor suppression, dose-limiting toxicity and wellbeing with the fetal estrogen estetrol in patients with advanced breast cancer

Marcus Schmidt, H. C. Coelingh Bennink, Y. Zimmerman, 2020, Journal of Cancer Research and Clinical Oncology.

Bleeding pattern and cycle control with estetrol-containing combined oral contraceptives: results from a phase II, randomised, dose-finding study (FIESTA).

J. Foidart, D. Apter, H. C. Coelingh Bennink, 2016, Contraception.

Mood disturbances during combined oral contraceptive use and the effect of androgen supplementation. Results of a double-blind, placebo-controlled, single-case alternation design pilot study

P. Onghena, H. C. Coelingh Bennink, F. Roumen, 2017, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

The bioequivalence of the contraceptive steroids ethinylestradiol and drospirenone is not affected by co-administration of dehydroepiandrosterone

H. C. Coelingh Bennink, Y. Zimmerman, W. Wouters, 2013, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Maintaining bone health by estrogen therapy in patients with advanced prostate cancer: a narrative review

H. V. van Melick, D. Somford, N. Clarke, 2022, Endocrine connections.

Estetrol combined with drospirenone: an oral contraceptive with high acceptability, user satisfaction, well-being and favourable body weight control

J. Foidart, D. Apter, H. C. Coelingh Bennink, 2017, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Response to the editorial 'Menopausal health: the potential for fetal-placental estrogen use'.

J. Foidart, H. C. Coelingh Bennink, C. Verhoeven, 2016, Maturitas.

A tumor cell specific Zona Pellucida glycoprotein 3 RNA transcript encodes an intracellular cancer antigen

P. V. van Diest, H. C. Coelingh Bennink, C. Moelans, 2023, Frontiers in oncology.